Belite Bio (BLTE) Tax Rate (2023 - 2024)
Belite Bio (BLTE) posted quarterly Tax Rate of 0.07% for Q3 2024, up 8.0% year-over-year from 0.06% in Q4 2023, and up 190.53% quarter-over-quarter from 0.08% in Q1 2024.
Belite Bio (BLTE) Tax Rate (2023 - 2024) Analysis & Trends
Belite Bio's Tax Rate history runs 2 years deep, the most recent figure standing at 0.07% for Q3 2024.
- In Q3 2024, Tax Rate rose 8.0% year-over-year to 0.07%; the TTM figure through Dec 2024 stood at 0.0% (up 7.0% YoY), while the FY2025 annual figure was 0.18%, up 19.0% from the prior year.
- Tax Rate for Q3 2024 stood at 0.07%, up from 0.08% in the prior quarter.
- The five-year high for Tax Rate was 0.07% in Q3 2024, with the low at 0.09% in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.91% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 24.15% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9.47% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 7.49% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.71% |
| 10 | Belite Bio | 6.40 Bn | 6.40 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 0.07% |
| Sep 30, 2024 | 0.07% |
| Sep 30, 2024 | 0.07% |
| Mar 31, 2024 | -0.08% |
| Mar 31, 2024 | -0.08% |
| Mar 31, 2024 | -0.08% |
| Dec 31, 2023 | 0.01% |
| Dec 31, 2023 | 0.01% |
| Dec 31, 2023 | 0.01% |
| Sep 30, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.04% |
| Jun 30, 2023 | -0.04% |
| Jun 30, 2023 | -0.04% |
| Mar 31, 2023 | -0.09% |
| Mar 31, 2023 | -0.09% |
| Mar 31, 2023 | -0.09% |